Cyclacel buying NC’s Align Pharmaceuticals
Cary, NC—Cyclacel Phamaceuticals Inc. (CYCC.O) is acquiring all of the assets of Cary, NC-based Align Pharmaceuticals for from $3.3 to $3.8 million in cash.
Align, founded in 2005, sells three drugs for managing the effects of radiation or chemotherapy in cancer patients.
Cyclacel says it plans to move Align’s operations to New Jersey. Cyclacel is developing a number of cancer and blood related products.
“The acquired business provides Cyclacel with the foundation to build a commercial organization focused on cancer that is complementary to Cyclacel’s oncology/hematology products in development,” the company said.
On the Web: www.alignpharma.com
As seen in Tech Journal South:
http://www.techjournalsouth.com/news/article.html?item_id=4030

